Epiliquid

Epigenomics

This molecular diagnostics company develops blood-based liquid biopsy tests for the early detection and screening of cancer for healthcare providers and clinical laboratories.

Glycanostics

This digital health company develops non-invasive liquid biopsy tests for early-stage cancer detection, serving clinical laboratories, hospitals and oncology professionals.

Avant Genomics

The company develops an automated platform for liquid biopsy sample preparation to assist clinical laboratories in cancer detection and monitoring.

Infiniplex

This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.

Oncoliq

This company develops liquid biopsy tests using molecular biology and machine learning for early cancer detection in clinical and screening settings.

LiquidCell Dx

This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.

Foresight Diagnostics

This company develops liquid biopsy tests to detect minimal residual disease in cancer patients for biopharmaceutical companies and healthcare providers.

Elphogene

This biotechnology company develops a molecular liquid biopsy test to monitor cancer progression and treatment efficacy for oncology patients and healthcare professionals.